Diflucan from Pfizer Ophthalmics

View other Anti-Fungal Agents

Description

DIFLUCAN® (fluconazole), the first of a new subclass of synthetic triazole antifungal agents, is available as tablets for oral administration, as a powder for oral suspension and as a sterile solution for intravenous use in glass and in Viaflex® Plus plastic containers.
  • Detailed Specifications
  • ItemDiflucan
  • CompanyPfizer Ophthalmics
  • PriceInquire
  • SizeTablets: 50 mg, 100 mg, 150 mg, 200 mg
    Oral Suspension: 350 mg, 1400 mg
    Injections: 100 mL, 200 mL
  • IndicationDIFLUCAN (fluconazole) is indicated for the treatment of:
    1. Vaginal candidiasis (vaginal yeast infections due to Candida).
    2. Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, DIFLUCAN was also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia.
    3. Cryptococcal meningitis. Before prescribing DIFLUCAN (fluconazole) for AIDS patients with cryptococcal meningitis, please see CLINICAL STUDIES section. Studies comparing
    DIFLUCAN to amphotericin B in non-HIV infected patients have not been conducted.
    Prophylaxis.
    DIFLUCAN is also indicated to decrease the incidence of candidiasis in patients undergoing bone marrow transplantation who receive cytotoxic chemotherapy and/or radiation therapy.
  • StorageTablets: Store below 86° F (30° C)
    Oral Suspension: Store dry powder below 86° F (30° C). Store reconstituted suspension between 86° F (30° C) and 41° F (5° C) and discard unused portion after 2 weeks. Protect from freezing.
    Injections: Store between 86° F (30° C) and 41° F (5° C). Protect from freezing.
  • How SuppliedTablets / Injection / Oral Suspension
  • Generic NameFluconazole